Net cash proceeds from XPDI merger
Company: Core Scientific
The claim, verbatim
The merger provided approximately $195.0 million in net cash proceeds to Core Scientific after payment of transaction expenses.
Source (primary)
Core Scientific 424B3 filed 2022-08-22 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “The Merger provided gross proceeds of approximately $221.6 million from the XPDI trust account, resulting in approximately $195.0 million in net cash proceeds to Core Scientific, after the payment of transaction expenses”
How we checked this
Checked on September 22, 2026. The cited source supports every part of this claim.
The document states approximately $195.0 million in net cash proceeds to Core Scientific after payment of transaction expenses.
Confirmed in the source:
- The merger provided approximately $195.0 million in net cash proceeds to Core Scientific
- This figure is after payment of transaction expenses
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000162828022023415/q22022corescientificinc-42.htm) in full (504,757 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 424B3 filed 2022-08-22
Quote: “The Merger provided gross proceeds of approximately $221.6 million from the XPDI trust account, resulting in approximately $195.0 million in net cash proceeds to Core Scientific, after the payment of transaction expenses”